Deutsche Bank’s China Biologic Products Holdings, Inc. CBPO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-4,070
| Closed | -$482K | – | 5023 |
|
|
2021
Q1 | $482K | Sell |
4,070
-1,199
| -23% | -$142K | ﹤0.01% | 3126 |
|
|
2020
Q4 | $623K | Sell |
5,269
-173,112
| -97% | -$20.1M | ﹤0.01% | 2755 |
|
|
2020
Q3 | $19.8M | Buy |
178,381
+177,419
| +18,443% | +$19.1M | 0.01% | 713 |
|
|
2020
Q2 | $98K | Sell |
962
-9,046
| -90% | -$968K | ﹤0.01% | 3445 |
|
|
2020
Q1 | $1.08M | Buy |
10,008
+9,942
| +15,064% | +$1.14M | ﹤0.01% | 2050 |
|
|
2019
Q4 | $6K | Sell |
66
-18
| -21% | -$2.08K | ﹤0.01% | 4643 |
|
|
2019
Q3 | $8K | Sell |
84
-343
| -80% | -$34.1K | ﹤0.01% | 4574 |
|
|
2019
Q2 | $40K | Sell |
427
-924
| -68% | -$87K | ﹤0.01% | 4606 |
|
|
2019
Q1 | $122K | Buy |
1,351
+1,301
| +2,602% | +$106K | ﹤0.01% | 4229 |
|
|
2018
Q4 | $3K | Hold |
50
| – | – | ﹤0.01% | 5053 |
|
|
2018
Q3 | $4K | Sell |
50
-69,080
| -100% | -$6.44M | ﹤0.01% | 5214 |
|
|
2018
Q2 | $6.87M | Buy |
69,130
+46,630
| +207% | +$4.03M | ﹤0.01% | 2062 |
|
|
2018
Q1 | $1.82M | Sell |
22,500
-37,373
| -62% | -$3.02M | ﹤0.01% | 2932 |
|
|
2017
Q4 | $4.72M | Sell |
59,873
-79,894
| -57% | -$6.64M | ﹤0.01% | 2076 |
|
|
2017
Q3 | $12.9M | Buy |
139,767
+85,039
| +155% | +$8.17M | 0.01% | 1282 |
|
|
2017
Q2 | $6.19M | Sell |
54,728
-45,862
| -46% | -$5.13M | ﹤0.01% | 1757 |
|
|
2017
Q1 | $10.1M | Buy |
100,590
+48,683
| +94% | +$5.2M | 0.01% | 1260 |
|
|
2016
Q4 | $5.58M | Sell |
51,907
-23,214
| -31% | -$2.71M | ﹤0.01% | 1607 |
|
|
2016
Q3 | $9.35M | Buy |
75,121
+56,353
| +300% | +$6.65M | 0.01% | 1354 |
|
|
2016
Q2 | $1.99M | Sell |
18,768
-6,198
| -25% | -$720K | ﹤0.01% | 2397 |
|
|
2016
Q1 | $2.86M | Sell |
24,966
-93,437
| -79% | -$11M | ﹤0.01% | 2126 |
|
|
2015
Q4 | $16.9M | Sell |
118,403
-32,536
| -22% | -$3.76M | 0.01% | 1012 |
|
|
2015
Q3 | $13.6M | Buy |
150,939
+35,695
| +31% | +$3.77M | 0.01% | 1125 |
|
|
2015
Q2 | $13.3M | Buy |
115,244
+15,128
| +15% | +$1.59M | 0.01% | 1169 |
|
|
2015
Q1 | $9.56M | Sell |
100,116
-1,728
| -2% | -$129K | 0.01% | 1372 |
|
|
2014
Q4 | $6.85M | Buy |
+101,844
| New | +$6.31M | ﹤0.01% | 1704 |
|
|
2014
Q2 | – | Sell |
-167
| Closed | -$5K | – | 6209 |
|
|
2014
Q1 | $5K | Buy |
+167
| New | +$5.32K | ﹤0.01% | 5200 |
|
Deutsche Bank's CBPO Position: Q2 2021 in Review
Deutsche Bank sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 4,070 shares — an estimated $482K sold.
Deutsche Bank first reported a position in CBPO in Q1 2014 and held it in 27 quarters. The position peaked at $19.8M in Q3 2020. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.
- Deutsche Bank reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
- Deutsche Bank sold 4,070 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $482K.
- Deutsche Bank first reported a position in China Biologic Products Holdings, Inc. in Q1 2014 and held it in 27 quarters.
- Deutsche Bank's China Biologic Products Holdings, Inc. position peaked at $19.8M in Q3 2020.
- 0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.
Based on Deutsche Bank's 13F filing for Q2 2021, filed 11 Aug 2021.